Key facts
- This page summarizes Michael Fleck's Form 4 filing for CYREN Ltd..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Mar 2022, 17:06.
Michael Fleck - 24 Mar 2022 Form 4 Insider Report for CYREN Ltd.
- Reporting relationship
- VP Marketing
- Issuer ticker
- N/A
- Reported as of
- 24 Mar 2022
- Net transaction value
- -$778
- SEC form
- 4
- Accepted by SEC
- 28 Mar 2022, 17:06:52 UTC
- Prior SEC filing
- 23 Jul 2021
- Next SEC filing
- 23 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Fleck
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Fleck filed Form 4 for CYREN Ltd. on 28 Mar 2022.
Change
- Previous filing in this sequence was filed on 23 Jul 2021.
- Current net transaction value: -$778.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYRN
transaction
Ordinary Shares
Sale
- Transaction value
- $778
- Shares
- -101
- Change %
- -0.03%
- Price
- $7.70*
- Shares after
- 314,899
- Date
- 24 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYRN
holding
Derivative
Options (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 75,000
- Date
- 24 Mar 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 75,000
- Exercise price
- $1.72
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
An aggregate of 10,000 restricted stock units held by the reporting person vested and settled on March 24, 2022. The Reporting Person sold the reported shares to cover the tax liability associated with the vesting of the restricted stock units.
Footnote F2
These Options (Right to Buy) vest 25% on August 11, 2021 and then monthly over the next three years.